Irisin's effects on adipocyte development have been outlined previously; however, its predominant anti-obesity action may lie in the modulation of energy balance, particularly expenditure, a critical contributor to postmenopausal obesity, and by extension MetS. Here, FNDC5 is linked to obesity disorder.